Brainstorm Cell Therapeutics

Established 2000

+ Selected Business
Add to Favorites
Hebrew Name

בריינסטורם תרפיה תאית בע"מ

Email Address
[email protected]
Phone Number
Fax Number
Mailing Address
12 Bazel, PETAH TIKVA 4951006
Brainstorm Cell Therapeutics



BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind stem cell therapies derived from autologous bone marrow cells for the treatment of highly debilitating neurodegenerative diseases. NurOwn, the company’s novel stem cell technology, reprograms the patient’s mesenchymal stem cells (MSC) into highly specialized, neuron-supporting cells that are then transplanted back into the spine or muscle tissue. The company holds the rights to develop and commercialize NurOwn through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.


Fields of Activity

  • Chemicals
  • Hitech
  • Medicines
  • Pharmaceuticals
  • Laboratories and research institutions
  • Associations and Organizations
  • Research - R&D
  • Research and development
  • Medical laboratories
  • Medical Research And Development
  • Medical Chemicals
  • Biological Research
  • Production of pharmaceutical substances
  • Medical equipment
  • Life Sciences


  • Medicines
  • clinical research
  • Research services
  • Medical research
  • Biological research
  • Pharmaceutical preparations
  • clinical experiments
  • High-tech industries
  • Drugs and drug proprietaries
  • Therapeutics
  • Drugs, proprietaries, and sundries

Executives working in Brainstorm Cell Therapeutics

Photo of Company Manager

Jacob Frenkel, Prof.

Photo of Company Manager

Chaim Lebovitz

Photo of Company Manager

Ralph Kern, MD.

President & Chief Medical Officer
Photo of Company Manager

Uri Yablonka

Chief Business Officer
Photo of Company Manager

Preetam Shah

Chief Financial Officer
Photo of Company Manager

David Setboun, Dr.

VP operations
Photo of Company Manager

Stacy Lindborg, Dr.

EVP Head of Global Clinical Research
Photo of Company Manager

William White

EVP Head of Market Access and Pricing
Photo of Company Manager

Mary Kay Turner

Vice President of Patient Advocacy and Government Affairs
Photo of Company Manager

Yael Gothelf, Dr.

VP Scientific and Regulatory Affairs
Photo of Company Manager

Yossef Levy, Dr.

VP Cell Production
Photo of Company Manager

Revital Aricha, Dr.

VP R & D

Business Data According to

Company Registration Number 513601021


Parent Company Brainstorm Cell Therapeutics Inc.




Contact This Business

An error occurred